Ticker LaunchRegulation A · Tier 2 · DARE
Dare Bioscience, Inc.
Dare Bioscience, Inc. (DARE) filed a Tier 2 Regulation A offering statement (Form 1-A) on Nov 25, 2025 for up to $24.3M at $5.00 per security. The SEC qualified the offering on Jan 5, 2026. Its securities are listed on Nasdaq under DARE. Underwriter or broker: D, i and g.
- Status
- Qualified
- Tier
- Tier 2
- Offering size
- $24.3M
- Offer price
- $5.00
- Security type
- Equity (common or preferred stock)
- Filed
- Nov 25, 2025
- Qualified
- Jan 5, 2026
- Ticker
- DARE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- State
- CA
- Underwriter / broker
- D, i, g, t, a, l, O, f, e, r, n, ,, L and C
More on this offering for subscribers
- Revenue, net income and total assets from the offering statement
- Employees
- Market cap at the offer price
- Auditor
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Offering statement (Form 1-A) Nov 25, 2025
- Final offering circular (253G2)
- All filings on EDGAR CIK 1401914
Other qualified Biotech & pharma Reg A offerings
- Bio-Path Holdings, Inc.Apr 28, 2026 · $600K
- Cannabis Bioscience International Holdings, Inc.Apr 13, 2026 · $2.5M
- Niihara International, Inc.Feb 6, 2026 · $20M
- Bio Essence CorpJan 5, 2026 · $5M
- Regen BioPharma IncDec 3, 2025 · $1.2M
- Regen BioPharma IncSep 5, 2025 · $2.5M